Stanford Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 21.19 Cr
as on 16-11-2024
- Revenue %
(FY 2023)
- Profit 36.62%
(FY 2023)
- Ebitda -3.03%
(FY 2023)
- Net Worth -14.11%
(FY 2023)
- Total Assets -4.89%
(FY 2023)
About Stanford Life Sciences
The Corporate was formerly known as Shallotcom Consulting Private Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹21.19 Cr.
Sanjeev Chauhan, Sunil Singh, and Geetika Mahandru serve as directors at the Company.
- CIN/LLPIN
U74900DL2007PTC161786
- Company No.
161786
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Apr 2007
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Stanford Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Chauhan  | Director | 27-Feb-2024 | Current |
| Sunil Singh | Director | 19-Apr-2017 | Current |
| Geetika Mahandru | Director | 08-Nov-2022 | Current |
Financial Performance of Stanford Life Sciences.
Stanford Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 36.62% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stanford Life Sciences?
In 2023, Stanford Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indospirit Marketing Private LimitedActive 10 years 11 monthsSanjeev Chauhan and Sunil Singh are mutual person
- A 2 Z Trade Links Private LimitedActive 20 years 1 month
Sanjeev Chauhan and Sunil Singh are mutual person
- Indospirit Loginext Private LimitedActive 12 years 1 month
Sanjeev Chauhan and Sunil Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Mar 2021 | ₹5.40 M | Open |
Others Creation Date: 31 Jan 2019 | ₹6.86 Cr | Open |
Others Creation Date: 31 Jan 2019 | ₹2.79 Cr | Open |
How Many Employees Work at Stanford Life Sciences?
Unlock and access historical data on people associated with Stanford Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stanford Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stanford Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
